Crossmark

Demethylation by low-dose 5-aza-2′-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma

Crossref DOI link: https://doi.org/10.1186/s13148-018-0600-2

Published Online: 2019-01-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Desjobert, Cécile

Carrier, Arnaud

Delmas, Audrey

Marzese, Diego M.

Daunay, Antoine

Busato, Florence

Pillon, Arnaud

Tost, Jörg

Riond, Joëlle

Favre, Gilles

Etievant, Chantal

Arimondo, Paola B. https://orcid.org/0000-0001-5175-4396
License Information

Text and Data Mining valid from 2019-01-16
More Information

Article History

Received: 4 October 2018

Accepted: 17 December 2018

First Online: 16 January 2019

Ethics approval and consent to participate

: Informed consent was obtained from all subjects, and experiments were performed according to the principles set out in the WMA Declaration of Helsinki and the NIH Belmont Report. Tissue specimens were coded according to HIPAA recommendations to ensure the confidentiality of the patients.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below